Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,703
Total Claims
$996K
Drug Cost
657
Beneficiaries
$1,516
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+42%
Cost per patient vs peers
$1,516 vs $1,068 avg
+25%
Brand preference vs peers
11.2% vs 9.0% avg
Brand vs Generic
Brand: 1,310 claims · $715K
Generic: 10,341 claims · $278K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 123 | $133K |
| Apixaban | 159 | $119K |
| Insulin Glargine,hum.Rec.Anlog | 64 | $42K |
| Rivaroxaban | 41 | $41K |
| Sitagliptin Phosphate | 35 | $33K |
| Empagliflozin | 30 | $33K |
| Rosuvastatin Calcium | 304 | $32K |
| Semaglutide | 29 | $30K |
| Budesonide/Formoterol Fumarate | 62 | $30K |
| Fluticasone/Umeclidin/Vilanter | 25 | $27K |
| Insulin Detemir | 32 | $26K |
| Tiotropium Bromide | 23 | $20K |
| Sacubitril/Valsartan | 15 | $16K |
| Fluticasone Propion/Salmeterol | 33 | $15K |
| Umeclidinium Bromide | 33 | $11K |
Prescribing Profile
Patient Profile
73
Avg Age
53%
Female
1.15
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data